CPAI vs. SBIO ETF Comparison

Comparison of Counterpoint Quantitative Equity ETF (CPAI) to ALPS Medical Breakthroughs ETF (SBIO)
CPAI

Counterpoint Quantitative Equity ETF

CPAI Description

CPAI employs a quantitative, model-driven strategy that integrates quantitative analysis and machine learning insights to navigate diverse market conditions. The portfolio consists of at least 50 US-listed companies of any capitalization or ADRs. The selection process relies on advanced quantitative models leveraging machine learning technology, considering over 30 variables related to value, long-term reversal, momentum, profitability, investor sentiment, and stock price stability. Additionally, the Adviser backtests variable combinations considered to be supported by economic reasoning or investor behavioral biases. The models continually learn and adapt relationships between input variables and realized historic returns, updating during quarterly portfolio rebalances. Moreover, rebalancing ensures the portfolio aligns with the models' rankings, with adjustments made to limit sector exposure to 35% or less.

Grade (RS Rating)

Last Trade

$33.22

Average Daily Volume

5,409

Number of Holdings *

10

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$37.52

Average Daily Volume

5,405

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period CPAI SBIO
30 Days 3.75% 0.28%
60 Days 10.51% 5.57%
90 Days 5.31% 14.48%
12 Months 43.61%
0 Overlapping Holdings
Symbol Grade Weight in CPAI Weight in SBIO Overlap
CPAI Overweight 10 Positions Relative to SBIO
Symbol Grade Weight
CVLT C 2.53%
MCY B 2.48%
PPC A 2.39%
WGS B 2.37%
THC C 2.36%
JXN B 2.36%
UNFI B 2.29%
COOP C 2.25%
MSI A 2.24%
TRGP C 2.23%
CPAI Underweight 83 Positions Relative to SBIO
Symbol Grade Weight
KRYS D -3.47%
ALKS C -3.16%
ACLX C -3.01%
DNLI C -2.92%
RNA A -2.88%
IMVT F -2.85%
CORT B -2.81%
CRNX D -2.8%
MRUS D -2.22%
FOLD F -2.15%
XENE F -2.03%
GERN D -1.85%
PTCT C -1.83%
EWTX B -1.82%
CLDX F -1.79%
ACAD F -1.79%
AGIO D -1.77%
PTGX C -1.77%
IDYA F -1.76%
CGON C -1.72%
VRNA C -1.57%
VCEL F -1.54%
VERA C -1.52%
NTLA F -1.46%
ZLAB C -1.42%
KROS C -1.36%
GLPG D -1.32%
AKRO C -1.28%
MIRM D -1.22%
MNKD C -1.2%
ARVN F -1.15%
BCRX D -1.11%
IMCR F -1.1%
KURA D -1.06%
SNDX F -1.04%
RCUS F -1.01%
VRDN B -0.95%
SPRY C -0.95%
TARS C -0.86%
XNCR D -0.86%
DAWN D -0.82%
IRON C -0.79%
PRTA F -0.77%
PHVS D -0.75%
LBPH D -0.74%
COGT C -0.69%
ANAB D -0.68%
AUPH C -0.68%
APLT B -0.6%
ETNB F -0.54%
LQDA F -0.52%
ERAS D -0.51%
OLMA D -0.5%
PLRX F -0.5%
IRWD F -0.47%
FDMT F -0.46%
FLGT F -0.45%
REPL C -0.45%
ANNX C -0.42%
SVRA D -0.42%
MLYS C -0.4%
ALLO F -0.4%
YMAB D -0.4%
ALEC F -0.39%
ARCT D -0.37%
CELC F -0.35%
ALT F -0.35%
URGN F -0.33%
CMPS F -0.33%
AURA D -0.32%
AVXL D -0.32%
ITOS F -0.27%
GHRS F -0.27%
TBPH F -0.26%
INZY D -0.24%
ALDX C -0.24%
ACIU C -0.24%
STRO F -0.21%
ZNTL D -0.2%
VNDA F -0.18%
ENTA F -0.16%
FULC F -0.14%
HLVX F -0.06%
Compare ETFs